Please provide your email address to receive an email when new articles are posted on . The model predicted MS diagnosis with 91.5% specificity and non-MS diagnosis with 100% specificity. However, it ...
To provide the right treatment for multiple sclerosis (MS), it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently ...
Clinicians and researchers have suspected for years that an aggressive, less-common form of multiple sclerosis (MS) is likely a distinct form of the disease. Now, new research conducted using a more ...
Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.
To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...
To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...
Please provide your email address to receive an email when new articles are posted on . A machine-learning model produced 46,644 estimated scores on a disability scale from 3,404 scores. Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results